09/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

09/2023

Sep 27, 2023, 17:22 | Blog
David Kirsch: I think Dr. M. Vera Peters would qualify as a famous radiation oncologist.
David Kirsch, Radiation Oncologist at Princess Margaret Cancer Centre, recently tweeted: "I think Dr. M.…
Sep 27, 2023, 17:12 | Opinion
Rasha Aboelhassan: Even if we did not win today, the next generation will.
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post by National Cancer Institute…
Sep 27, 2023, 17:05 | Career
Abi Siva: Excited to announce that I am joining the MUSC Hollings Cancer Center as the Director of Medical Oncology!
Abi Siva, Director of the Community Cancer Center at Upstate Medical University, recently shared on…
Sep 27, 2023, 16:57 | Blog
Hidehito Horinouchi: Reconsidering the cutoff for sensitive and refractory relapses in ES-SCLC in the era of ICIs in JTO and JTO CRR by Dr. Masahiro Torasawa.
Hidehito Horinouchi, Assistant Chief of the Department of Thoracic Oncology at National Cancer Center Hospital,…
Sep 27, 2023, 16:52 | Opinion
Ross Levine: IMHO, the biggest risks/barriers for physician scientists are...
Ross Levine, Leukemia Specialist and Physician-Scientist at Memorial Sloan Kettering Cancer Center, recently shared on X/Twitter:…
Sep 27, 2023, 16:38 | Societies
Lynn M. Schuchter: Global oncology community coming together at 4th annual meeting of Emirates Oncology Society.
Lynn M. Schuchter, shared on X/Twitter: "Global oncology community coming together at 4th annual meeting…
Sep 26, 2023, 19:22 | Blog
Isabel Mestres: I will be sharing the exciting news about C/Can's new research initative at the Cancer Discovery Virtual Symposium organised by the American Association for Cancer Research on 26 September.
Sep 26, 2023, 19:21 | Blog
Bishal Gyawali: We are pleased and proud to announce the inaugural Common Sense Oncology Fellowship in Cancer Policy based at the Division of Cancer Care and Epidemiology in Kingston, Ontario.
Sep 26, 2023, 19:21 | Insight
Vivek Subbiah: A clinical trial is not a last resort but can be a first option for people facing cancer.
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post by…
Sep 26, 2023, 19:20 | Insight
Venkatraman Radhakrishnan: Reduction in chemo dose intensity by 25% and adding Rituximab improves survival in pediatric high-grade B Non-Hodgkins Lymphoma in resource-limited settings.
All: 695 Posts: 101 - 110